PBS to remove common testosterone hormone replacement therapy
The Department of Health, through the Pharmaceutical Benefits Scheme (PBS), has announced that from February 1st they will no longer subsidise Primoteston Depot, the most common form of medical transition available for transgender men and non-binary people assigned female at birth. “Primoteston Depot (testosterone enantate 250 mg injection) will be deleted from the Pharmaceutical Benefits […]